Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Achillion Pharmaceuticals, Inc. To Contact The Firm
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Achillion Pharmaceuticals, Inc. (“Achillion” or the “Company”) (NASDAQ: ACHN) of the December 9, 2013 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against Achillion and certain executives.
A complaint has been filed on behalf of all persons who purchased Achillion securities between April 21, 2012 and September 27, 2013 (the “Class Period”) in the District of Connecticut.
The complaint alleges that the Company and its executives violated federal securities laws with respect to its disclosures concerning its business, operations, and prospects.
Specifically, the action alleges that throughout the Class Period Achillion issued false and/or misleading statements regarding the effect of sovaprevir, the Company’s investigative hepatitis drug, on liver enzyme elevations.
On July 1, 2013, the Company disclosed that the FDA had placed a clinical hold on sovaprevir after elevations in liver enzymes were noted in a Phase I trial. Then, on September 27, 2013, Achillion announced that it had received a response from the FDA effectively informing the Company that the removal of the clinical hold was not warranted.
Following this news, the Company’s stock declined $4.22 per share, or over 58%, to close at $3.02 per share on September 30, 2013.
If you invested in Achillion stock or options between April 21, 2012 and September 27, 2013 and would like to discuss your legal rights, you can contact us by calling Richard Gonnello or Francis McConville toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to email@example.com or firstname.lastname@example.org. Faruqi & Faruqi, LLP also encourages anyone with information regarding Achillion’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
Richard W. Gonnello
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330
If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.